Selected research
Industry Growth & Trends
Global EMOCAP Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global EMOCAP market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for EMOCAP is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for EMOCAP is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for EMOCAP is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the EMOCAP market include StretchSense, Noitom, Vicon, Cyber Glove Systems, Rokoko, MANUS, AiQ Synertial, Virtual Motion Labs and PhaseSpace, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global EMOCAP market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The EMOCAP market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global EMOCAP market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to EMOCAP.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global EMOCAP market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
EMOCAP Market by Company
StretchSense
Noitom
Vicon
Cyber Glove Systems
Rokoko
MANUS
AiQ Synertial
Virtual Motion Labs
PhaseSpace
VRTRIX
HaptX
Virdyn
Qualisys AB
Xsens Technologyes
Optitrack
Codamotion
PTI Phoenix Technologies
Noraxon USA
NTT Data
EMOCAP Segment by Type
Whole Boby
Part Boby
EMOCAP Segment by Application
Scientific Research
Entertainment
Medical
Other
EMOCAP Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EMOCAP market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of EMOCAP and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EMOCAP.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of EMOCAP companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Whole Boby
- Part Boby
Applications
- Scientific Research
- Entertainment
- Medical
- Other
Companies covered
- StretchSense
- Noitom
- Vicon
- Cyber Glove Systems
- Rokoko
- MANUS
- AiQ Synertial
- Virtual Motion Labs
- PhaseSpace
- VRTRIX
- HaptX
- Virdyn
- Qualisys AB
- Xsens Technologyes
- Optitrack
- Codamotion
- PTI Phoenix Technologies
- Noraxon USA
- NTT Data
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global EMOCAP Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global EMOCAP Market Size by Region (2021-2032)
- 1.4.1 Global EMOCAP Market Size by Region (2021-2026)
- 1.4.2 Global EMOCAP Market Size by Region (2027-2032)
- 1.5 Key Regions EMOCAP Market Size (2021-2032)
- 1.5.1 North America EMOCAP Market Size Growth Rate (2021-2032)
- 1.5.2 Europe EMOCAP Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific EMOCAP Market Size Growth Rate (2021-2032)
- 1.5.4 South America EMOCAP Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa EMOCAP Market Size Growth Rate (2021-2032)
2 EMOCAP Market by Type
- 2.1 Type Introduction
- 2.1.1 Whole Boby
- 2.1.2 Part Boby
- 2.2 Global EMOCAP Market Size by Type
- 2.2.1 Global EMOCAP Market Size Overview by Type (2021-2032)
- 2.2.2 Global EMOCAP Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global EMOCAP Market Size Forecasted by Type (2027-2032)
- 2.3 Global EMOCAP Market Size by Regions
- 2.3.1 North America EMOCAP Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe EMOCAP Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific EMOCAP Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America EMOCAP Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa EMOCAP Market Size Breakdown by Type (2021-2026)
3 EMOCAP Market by Application
- 3.1 Type Introduction
- 3.1.1 Scientific Research
- 3.1.2 Entertainment
- 3.1.3 Medical
- 3.1.4 Other
- 3.2 Global EMOCAP Market Size by Application
- 3.2.1 Global EMOCAP Market Size Overview by Application (2021-2032)
- 3.2.2 Global EMOCAP Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global EMOCAP Market Size Forecasted by Application (2027-2032)
- 3.3 Global EMOCAP Market Size by Regions
- 3.3.1 North America EMOCAP Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe EMOCAP Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific EMOCAP Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America EMOCAP Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa EMOCAP Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 EMOCAP Industry Trends
- 4.2 EMOCAP Industry Drivers
- 4.3 EMOCAP Industry Opportunities and Challenges
- 4.4 EMOCAP Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by EMOCAP Revenue (2021-2026)
- 5.2 Global EMOCAP Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global EMOCAP Key Company Headquarters & Area Served
- 5.4 Global EMOCAP Company, Product Type & Application
- 5.5 Global EMOCAP Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global EMOCAP Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 EMOCAP Players Market Share by Revenue in 2025
- 5.6.3 2025 EMOCAP Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 StretchSense
- 6.1.1 StretchSense Company Information
- 6.1.2 StretchSense Business Overview
- 6.1.3 StretchSense EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 StretchSense EMOCAP Product Portfolio
- 6.1.5 StretchSense Recent Developments
- 6.2 Noitom
- 6.2.1 Noitom Company Information
- 6.2.2 Noitom Business Overview
- 6.2.3 Noitom EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Noitom EMOCAP Product Portfolio
- 6.2.5 Noitom Recent Developments
- 6.3 Vicon
- 6.3.1 Vicon Company Information
- 6.3.2 Vicon Business Overview
- 6.3.3 Vicon EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Vicon EMOCAP Product Portfolio
- 6.3.5 Vicon Recent Developments
- 6.4 Cyber Glove Systems
- 6.4.1 Cyber Glove Systems Company Information
- 6.4.2 Cyber Glove Systems Business Overview
- 6.4.3 Cyber Glove Systems EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Cyber Glove Systems EMOCAP Product Portfolio
- 6.4.5 Cyber Glove Systems Recent Developments
- 6.5 Rokoko
- 6.5.1 Rokoko Company Information
- 6.5.2 Rokoko Business Overview
- 6.5.3 Rokoko EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Rokoko EMOCAP Product Portfolio
- 6.5.5 Rokoko Recent Developments
- 6.6 MANUS
- 6.6.1 MANUS Company Information
- 6.6.2 MANUS Business Overview
- 6.6.3 MANUS EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 MANUS EMOCAP Product Portfolio
- 6.6.5 MANUS Recent Developments
- 6.7 AiQ Synertial
- 6.7.1 AiQ Synertial Company Information
- 6.7.2 AiQ Synertial Business Overview
- 6.7.3 AiQ Synertial EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 AiQ Synertial EMOCAP Product Portfolio
- 6.7.5 AiQ Synertial Recent Developments
- 6.8 Virtual Motion Labs
- 6.8.1 Virtual Motion Labs Company Information
- 6.8.2 Virtual Motion Labs Business Overview
- 6.8.3 Virtual Motion Labs EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Virtual Motion Labs EMOCAP Product Portfolio
- 6.8.5 Virtual Motion Labs Recent Developments
- 6.9 PhaseSpace
- 6.9.1 PhaseSpace Company Information
- 6.9.2 PhaseSpace Business Overview
- 6.9.3 PhaseSpace EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 PhaseSpace EMOCAP Product Portfolio
- 6.9.5 PhaseSpace Recent Developments
- 6.10 VRTRIX
- 6.10.1 VRTRIX Company Information
- 6.10.2 VRTRIX Business Overview
- 6.10.3 VRTRIX EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 VRTRIX EMOCAP Product Portfolio
- 6.10.5 VRTRIX Recent Developments
- 6.11 HaptX
- 6.11.1 HaptX Company Information
- 6.11.2 HaptX Business Overview
- 6.11.3 HaptX EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 HaptX EMOCAP Product Portfolio
- 6.11.5 HaptX Recent Developments
- 6.12 Virdyn
- 6.12.1 Virdyn Company Information
- 6.12.2 Virdyn Business Overview
- 6.12.3 Virdyn EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Virdyn EMOCAP Product Portfolio
- 6.12.5 Virdyn Recent Developments
- 6.13 Qualisys AB
- 6.13.1 Qualisys AB Company Information
- 6.13.2 Qualisys AB Business Overview
- 6.13.3 Qualisys AB EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Qualisys AB EMOCAP Product Portfolio
- 6.13.5 Qualisys AB Recent Developments
- 6.14 Xsens Technologyes
- 6.14.1 Xsens Technologyes Company Information
- 6.14.2 Xsens Technologyes Business Overview
- 6.14.3 Xsens Technologyes EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 Xsens Technologyes EMOCAP Product Portfolio
- 6.14.5 Xsens Technologyes Recent Developments
- 6.15 Optitrack
- 6.15.1 Optitrack Company Information
- 6.15.2 Optitrack Business Overview
- 6.15.3 Optitrack EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Optitrack EMOCAP Product Portfolio
- 6.15.5 Optitrack Recent Developments
- 6.16 Codamotion
- 6.16.1 Codamotion Company Information
- 6.16.2 Codamotion Business Overview
- 6.16.3 Codamotion EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Codamotion EMOCAP Product Portfolio
- 6.16.5 Codamotion Recent Developments
- 6.17 PTI Phoenix Technologies
- 6.17.1 PTI Phoenix Technologies Company Information
- 6.17.2 PTI Phoenix Technologies Business Overview
- 6.17.3 PTI Phoenix Technologies EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
- 6.17.4 PTI Phoenix Technologies EMOCAP Product Portfolio
- 6.17.5 PTI Phoenix Technologies Recent Developments
- 6.18 Noraxon USA
- 6.18.1 Noraxon USA Company Information
- 6.18.2 Noraxon USA Business Overview
- 6.18.3 Noraxon USA EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
- 6.18.4 Noraxon USA EMOCAP Product Portfolio
- 6.18.5 Noraxon USA Recent Developments
- 6.19 NTT Data
- 6.19.1 NTT Data Company Information
- 6.19.2 NTT Data Business Overview
- 6.19.3 NTT Data EMOCAP Revenue, Global Share and Gross Margin (2021-2026)
- 6.19.4 NTT Data EMOCAP Product Portfolio
- 6.19.5 NTT Data Recent Developments
7 North America
- 7.1 North America EMOCAP Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America EMOCAP Market Size by Country (2021-2026)
- 7.3 North America EMOCAP Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe EMOCAP Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe EMOCAP Market Size by Country (2021-2026)
- 8.3 Europe EMOCAP Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific EMOCAP Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific EMOCAP Market Size by Country (2021-2026)
- 9.3 Asia-Pacific EMOCAP Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America EMOCAP Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America EMOCAP Market Size by Country (2021-2026)
- 10.3 South America EMOCAP Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa EMOCAP Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa EMOCAP Market Size by Country (2021-2026)
- 11.3 Middle East & Africa EMOCAP Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst